Showing 601 - 620 results of 111,838 for search '(( 10 ((ng decrease) OR (we decrease)) ) OR ( 50 ((n decrease) OR (a decrease)) ))', query time: 1.26s Refine Results
  1. 601
  2. 602

    Hedgehog signaling is decreased in <i>Foxa1</i>;<i>Foxa2</i> double knockouts. by Jennifer A. Maier (278698)

    Published 2013
    “…<i>Ptch1</i> expression was decreased in the tail of <i>Foxa1</i>;<i>Foxa2</i> double mutants (P) compared to control (M), <i>Foxa1</i> null (N) and <i>Foxa2</i> mutants (O). …”
  3. 603
  4. 604

    S10 Data - by Christoph Anders (4068499)

    Published 2024
    “…<div><p>Hysteresis refers to a physical phenomenon in which the response or state of a system depends on both the input variable and its history. …”
  5. 605
  6. 606
  7. 607

    Decrease in cell viability by siRNA and miRNA dependent induction of DTA. by Liraz Harel (675561)

    Published 2014
    “…<p>U251 cells were transfected with the indicated construct (50 ng) with (A) or without (B) siRNAs (10pmol). …”
  8. 608
  9. 609
  10. 610
  11. 611
  12. 612
  13. 613
  14. 614
  15. 615

    CNP decrease mitochondrial membrane potential and induce mitochondrial fragmentation in melanoma cells. by Elif Aplak (7430123)

    Published 2020
    “…<p>A, 300 μM CNP (4 h) significantly decreased mitochondrial membrane potential in A375 cells, but not in melanocytes, indicated by changes of TMRM dependent fluorescence in mitochondria. …”
  16. 616
  17. 617

    Drugs which cluster on the 'anxiolytic' group decrease 5-HT turnover in the brain. by Caio Maximino (100467)

    Published 2014
    “…A negative correlation is found between the decrease in serotonin turnover and the increase in time on white produced by a drug (r<sup>2</sup> = 0.5688, p = 0.0073).…”
  18. 618

    Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

    Published 2016
    “…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
  19. 619
  20. 620